The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The challenges patients face during intensive induction therapy
Thomas W. LeBlanc
June 21, 2021
During the 2021 ASCO Annual Meeting, Know AML spoke with Thomas W. LeBlanc, Duke University School of Medicine, Durham, US. We asked, What challenges do patients experience during intensive induction therapy and how to overcome them? LeBlanc describes psychological symptoms associated with receiving intensive chemotherapy, and proposes improvements to the patient experience. This involves the integration of specialist palliative care, which focuses on symptom assessment and management, and providing support for the patient and family.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.
